Intesity Therapeutics Inc (INTS)

Form 8-K - Current report

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award PR...

Form 8-K - Current report

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update PR...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation

Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation PR Newswire...

Form 8-K - Current report

Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update

Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US

Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US PR Newswire SHELTON...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]